Tirzepatide (GLP-2T)
Same-day shipping — Ships next business day, cutoff 3 PM ET.
≥99% purity verified by independent HPLC and mass spectrometry (MS) through Janoshik Analytical. Intended for laboratory research use only; not for human consumption, diagnosis, or treatment. View transparency report Compliance PDFs
Documentation & standards
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
- Research-Use-Only Compliance: What the Label Obligates
Advanced metabolic research compound. Studied in metabolic and energy pathway models. High-purity research-grade material.
Mix and match any items — discount applies automatically at checkout.
Reminder email when it's time to reorder. No card on file. Cancel anytime from your account — or email support@aresresearchlab.com.
Batch transparency
- Batch / lot
- Released with your order
- Testing lab
- Janoshik Analytical
- Purity (HPLC)
- ≥99% target spec
- Identity (MS)
- Available on request
- Report issued
- Available on request
- Full PDF report
- By request
Every request returns a reference number and a live status page. See all published batch records →
For laboratory research use only — not for human or veterinary use.
Earn 34 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for research and laboratory use only. Not for human consumption.
Tirzepatide (GLP-2T) — Dual-Agonist Research Compound
Tirzepatide, supplied by Ares Research as GLP-2T, is studied as a dual GIP and GLP-1 receptor agonist in laboratory metabolic-signaling models.
Within the Ares research line, GLP-2T (tirzepatide) supports controlled investigation of dual-receptor pathway interaction and comparison with single- and triple-agonist research compounds.
Third-party purity testing available upon request.
Key Features
- Advanced research-grade compound
- Dual-pathway research focus
- High-purity formulation
- Batch-tested consistency
Tirzepatide (GLP-2T) Research Applications
- Advanced metabolic pathway models
- Energy signaling research
- Multi-pathway interaction studies
Research Classification
Storage Information
Tirzepatide (GLP-2T) Purity & COA Verification
For laboratory research use only. Not for human consumption, diagnosis, or treatment.
What is tirzepatide?
Tirzepatide — supplied by Ares Research as GLP-2T — is an investigational synthetic peptide described in the scientific literature as a dual receptor agonist. Its defining molecular profile combines activity at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.
In the incretin-research sequence, semaglutide is characterised as a single GLP-1 receptor agonist, tirzepatide as the dual GIP/GLP-1 agonist, and retatrutide as an investigational triple agonist that adds glucagon-receptor activity. This receptor progression provides the basis for published comparisons of tirzepatide vs semaglutide and tirzepatide vs retatrutide.
Published tirzepatide research has examined metabolic-regulation and body-weight endpoints, including comparative studies in which measured endpoints differed from single-agonist comparators. These findings describe controlled research observations only; they do not establish suitability or an expected outcome for any person. GLP-2T is offered exclusively as laboratory research material.
Tirzepatide (GLP-2T) product specifications
| Compound | Tirzepatide (research designation GLP-2T) |
|---|---|
| Class | Synthetic peptide — dual receptor agonist (GIP / GLP-1) |
| Purity standard | ≥99% (HPLC, with identity confirmed by mass spectrometry) |
| Physical form | Lyophilised powder in a sealed glass vial |
| Available vial sizes | 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg and 60mg |
| Storage | Refrigerated and protected from light; batch handling documentation included |
| Testing | Third-party COA covering identity, purity, heavy metals, endotoxins and sterility |
| Origin | Synthesised and shipped domestically (USA) |
| Intended use | Laboratory research use only — not for human or veterinary use |
Tirzepatide COA and third-party verification
Every GLP-2T batch is independently tested before release. HPLC measures purity, mass spectrometry confirms molecular identity, and the published panel records heavy-metals, endotoxin and sterility screening where available. The third-party report is tied to the vial batch number so researchers can verify the source result rather than relying on a summary claim.
Testing documentation is supplied for laboratory research use only and does not support human, veterinary, diagnostic or therapeutic use.
Tirzepatide research questions
+What is tirzepatide (GLP-2T)?
Tirzepatide, supplied by Ares Research as GLP-2T, is an investigational synthetic peptide characterised in published literature as a dual GIP and GLP-1 receptor agonist. It is supplied strictly as laboratory research material and is not for human or veterinary use.
+How does tirzepatide differ from semaglutide and retatrutide?
The compounds differ by receptor profile: semaglutide is a single GLP-1 receptor agonist, tirzepatide is a dual GIP/GLP-1 receptor agonist, and retatrutide is an investigational triple GIP/GLP-1/glucagon receptor agonist. Published comparative research has examined metabolic-regulation and body-weight endpoints across these classes.
+How is GLP-2T tested?
Each GLP-2T batch undergoes independent analytical testing. HPLC measures purity, mass spectrometry confirms identity, and the testing panel also covers heavy metals, endotoxins and sterility.
+What purity standard does GLP-2T meet?
GLP-2T (tirzepatide) is produced to a ≥99% purity standard. The measured batch result and third-party Certificate of Analysis can be checked through the Ares Research COA lookup and transparency record.
+How is tirzepatide research material shipped?
GLP-2T is synthesised and shipped domestically from the United States with tracked delivery. Every vial is supplied exclusively for laboratory research use.
+How should GLP-2T be stored?
Keep sealed lyophilised material refrigerated, protected from light and moisture. After laboratory reconstitution, keep it refrigerated and follow the handling documentation supplied with the batch.
Tirzepatide (GLP-2T) — Compound Information & Scientific Literature
Reference data for laboratory personnel: molecular identity, storage and stability handling, our analytical testing panel, and peer-reviewed literature indexed on PubMed.
Molecular Profile
| Compound | Tirzepatide (GLP-2T) |
|---|---|
| Molecule type | Metabolic Research Compound |
| Class | Metabolic Research Compound |
| Catalog category | Metabolic Research |
| Physical format | Lyophilized vial |
Handling Reference
-20 °C, protected from light and moisture
24 months from date of manufacture in the sealed vial
2-8 °C (refrigerated), do not freeze after reconstitution
Stability studied out to approximately 28 days under continuous refrigeration
Analytical Testing Panel
Verified by Janoshik Analytical — full panel, every batch. Second independent lab confirmation is being added batch by batch.
Quantifies the main peak against related-substance peaks, so the stated purity percentage is measured rather than assumed.
Every Tirzepatide (GLP-2T) lot passes all 8 stages before it is released. Expand a stage to see the method and why we run it.
- Method on the COARP-HPLC (UV 214 nm)Why Ares runs it
Quantifies the main peak against related-substance peaks, so the stated purity percentage is measured rather than assumed.
- Method on the COAQuantitative HPLC mass/concentration assayWhy Ares runs it
Confirms the vial actually contains the labeled amount — purity alone says nothing about how much material is in the vial.
- Method on the COAMass Spectrometry (ESI-MS)Why Ares runs it
Confirms the measured molecular mass matches the declared compound — the check that catches a mislabeled or substituted vial.
- Method on the COAICP-MSWhy Ares runs it
Screens for elemental contaminants carried over from synthesis, reagents, or packaging.
- Method on the COAMembrane filtration, USP <71> methodologyWhy Ares runs it
Checks the finished lyophilized vial for microbial growth after fill and closure.
- Method on the COALAL assay (kinetic chromogenic)Why Ares runs it
Measures bacterial endotoxin load, a contamination marker that purity testing alone will not reveal.
- Method on the COAIndependent batch review against release specificationWhy Ares runs it
Ties the analytical numbers back to the paperwork — the lot you receive is the lot on the certificate.
- Method on the COALC-MS/MS targeted screenWhy Ares runs it
A contamination check most research suppliers never run, and the reason we run it on every batch regardless of compound.
PASS reflects the batch release standard every lot must meet before it ships. Per-lot results are published on that lot's Certificate of Analysis.
Peer-Reviewed References
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
Nauck MA et al. · Cardiovascular diabetology, 2022 · PMID 36050763
View sourceEfficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Rosenstock J et al. · Lancet (London, England), 2021 · PMID 34186022
View sourceMechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu QK · Frontiers in endocrinology, 2024 · PMID 39114288
View sourceTirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Willard FS et al. · JCI insight, 2020 · PMID 32730231
View sourceLY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Coskun T et al. · Molecular metabolism, 2018 · PMID 30473097
View source
References are listed for literature-identification purposes only. Ares Research is not affiliated with the authors, journals, or institutions cited.
This material is supplied for laboratory and research use only. It is not for human or veterinary use, and it is not a drug, food, or cosmetic. These statements have not been evaluated by the Food and Drug Administration. No information on this page is intended to diagnose, treat, cure, or prevent any condition.
How Ares compares for GLP-2T
Independent, documentation-first breakdowns of the vendors researchers most often ask about for this compound. COA verification, US shipping, and sourcing transparency, side by side.
Research Use Disclaimer
Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.
All testing documentation and COA data are provided for laboratory research use only and are not intended to support human consumption, diagnostic, or therapeutic use.
Independent Certificate of Analysis
Independently tested by Janoshik Analytical. Verified and batch-tracked by Ares Research. Additional reports available upon request.
No fillers. No shortcuts. Only verified compounds.
